Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2698061 | 0.93 | LMNA (0.63) | LMNATHRBBCHEACHEPTGS2 | |
| Ethylene SCHEMBL4424062 | 0.91 | LMNA (0.50) | LMNABCHEACHEPTGS2 | |
| Cyclohexanone SCHEMBL3835265 | 0.90 | LMNA (0.48) | LMNABCHEACHEPTGS2 | |
| Ethylene SCHEMBL3959533 | 0.86 | LMNA (0.44) | LMNA | |
| Ethylene SCHEMBL9049781 | 0.86 | LMNA (0.44) | LMNA | |
| Ethylene SCHEMBL3238455 | 0.85 | LMNA (0.43) | LMNA | |
| Ethylene SCHEMBL8915548 | 0.85 | LMNA (0.43) | LMNA | |
| Cyclohexanone SCHEMBL6517734 | 0.84 | LMNA (0.52) | LMNATHRBBCHEACHEPTGS2 | |
| Ethylene SCHEMBL2909659 | 0.83 | LMNA (0.50) | LMNABCHEACHEPTGS2 | |
| Ethylene SCHEMBL4935788 | 0.80 | LMNA (0.75) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250223717-A1 | COPPER PLATING ADDITIVE COMPOSITIONS, COPPER PLATING SOLUTIONS, AND USES THEREOF | JIANGYIN NANOPORE INNOVATIVE MATERIALS TECHNOLOGY LTD (CN) | 2025-07-10 | — | — | US | claimed |
| CN-115894181-A | Synthetic method of cyclohexenyl cyclohexyl difluorobenzene liquid crystal compound | 渭南高新区海泰新型电子材料有限责任公司 | 2023-04-04 | — | — | CN | claimed |
| CN-109705038-A | The synthetic method of huperzine | 广州市朗启医药科技有限责任公司 | 2019-05-03 | — | — | CN | claimed |
| US-10092786-B2 | Fire extinguishing composition comprising aldoketones compound | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) | 2018-10-09 | — | — | US | claimed |
| US-20160332016-A1 | Fire Extinguishing Composition Comprising Aldoketones Compound | NANO FIRE, LLC | 2016-11-17 | — | — | US | claimed |
| CN-105696360-A | PVC artificial leather capable of efficiently releasing negative ions and preparation method thereof | 储著国 | 2016-06-22 | — | — | CN | claimed |
| CN-102746269-A | New preparation process of 1, 4-cyclohexanedione monoethylene acetal | KAIHUA HUANG | 2012-10-24 | — | — | CN | claimed |
| EP-1010694-B1 | Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers | SERVIER LAB (FR) | 2003-08-06 | — | — | EP | claimed |
| EP-4617263-A1 | ARYL-CONTAINING AMINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Institute of Material Medica, Chinese Academy of Sciences (CN) | 2025-09-17 | — | — | EP | disclosed |
| US-20250236632-A1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2025-07-24 | — | — | US | disclosed |
| EP-3782994-B1 | COMPOUNDS USEFUL AS KINASE INHIBITORS | LOXO ONCOLOGY INC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250223717-A1 | COPPER PLATING ADDITIVE COMPOSITIONS, COPPER PLATING SOLUTIONS, AND USES THEREOF | JIANGYIN NANOPORE INNOVATIVE MATERIALS TECHNOLOGY LTD (CN) | 2025-07-10 | — | — | US | disclosed |
| US-20250223717-A1 | COPPER PLATING ADDITIVE COMPOSITIONS, COPPER PLATING SOLUTIONS, AND USES THEREOF | JIANGYIN NANOPORE INNOVATIVE MATERIALS TECHNOLOGY LTD (CN) | 2025-07-10 | — | — | US | disclosed |
| US-20250171431-A1 | HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2025-05-29 | — | — | US | disclosed |
| WO-1993003012-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |
| CN-1015711-B | Cycloalkaho [1,2-b] indole-sulphonamides | BAYER AG (DE) | 1992-03-04 | — | — | CN | disclosed |
| EP-0281661-B1 | 2-ALKOXYCARBONYL-4-(4-PYRIDYL)CYCLOHEXANONES AND PROCESS FOR PREPARING THEM | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-07-17 | — | — | EP | disclosed |
| US-4824952-A | CARDIOTONIC AGENTS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1989-04-25 | — | — | US | disclosed |
| CN-88100329-A | Cycloalkanes is [1,2-C:4,3-C '] two pyrazoles also | — | 1988-09-28 | — | — | CN | disclosed |
| CN-87100773-A | Cycloalkanes is [1,2-b] indoles-sulfamide compound also | — | 1987-09-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236632-A1 | BETA-LACTAMASE INHIBITORS | MGAM, GAA, LCT | LMNA 542/4885THRB 2487/4885BCHE 43/4885 |
| US-20250171431-A1 | HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE | IGF1R, TRHR, TSHR | LMNA 3056/4885THRB 8/4885BCHE 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.